[go: up one dir, main page]

GB201904771D0 - New pharmaceutical compositions - Google Patents

New pharmaceutical compositions

Info

Publication number
GB201904771D0
GB201904771D0 GBGB1904771.1A GB201904771A GB201904771D0 GB 201904771 D0 GB201904771 D0 GB 201904771D0 GB 201904771 A GB201904771 A GB 201904771A GB 201904771 D0 GB201904771 D0 GB 201904771D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
new pharmaceutical
new
compositions
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1904771.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orexo AB
Original Assignee
Orexo AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orexo AB filed Critical Orexo AB
Priority to GBGB1904771.1A priority Critical patent/GB201904771D0/en
Publication of GB201904771D0 publication Critical patent/GB201904771D0/en
Priority to PCT/GB2020/050892 priority patent/WO2020201768A1/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB1904771.1A 2019-04-04 2019-04-04 New pharmaceutical compositions Ceased GB201904771D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1904771.1A GB201904771D0 (en) 2019-04-04 2019-04-04 New pharmaceutical compositions
PCT/GB2020/050892 WO2020201768A1 (en) 2019-04-04 2020-04-03 Pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1904771.1A GB201904771D0 (en) 2019-04-04 2019-04-04 New pharmaceutical compositions

Publications (1)

Publication Number Publication Date
GB201904771D0 true GB201904771D0 (en) 2019-05-22

Family

ID=66809533

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1904771.1A Ceased GB201904771D0 (en) 2019-04-04 2019-04-04 New pharmaceutical compositions

Country Status (2)

Country Link
GB (1) GB201904771D0 (en)
WO (1) WO2020201768A1 (en)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9516268D0 (en) 1995-08-08 1995-10-11 Danbiosyst Uk Compositiion for enhanced uptake of polar drugs from the colon
FR2753376B1 (en) * 1996-09-18 1998-10-16 Synthelabo PHARMACEUTICAL COMPOSITIONS COMPRISING AMISULPRIDE AND THERAPEUTIC APPLICATIONS THEREOF
CN1826100B (en) 2003-07-17 2010-12-22 旗帜药物胶囊公司 Controlled release preparation
SI1765292T1 (en) 2004-06-12 2018-04-30 Collegium Pharmaceutical, Inc. Abuse-deterrent drug formulations
US20080286373A1 (en) 2007-05-18 2008-11-20 Palepu Nageswara R Ziprasidone formulations
RU2678833C2 (en) 2008-09-17 2019-02-04 Киазма Инк. Pharmaceutical compositions and related delivery methods
US20110142889A1 (en) 2009-12-16 2011-06-16 Nod Pharmaceuticals, Inc. Compositions and methods for oral drug delivery
EP3160444B1 (en) 2014-06-25 2021-11-24 Synergia Bio Sciences Private Limited A pharmaceutical oil-in-water nano-emulsion
CA2910865C (en) 2014-07-15 2016-11-29 Isa Odidi Compositions and methods for reducing overdose
US10265384B2 (en) 2015-01-29 2019-04-23 Novo Nordisk A/S Tablets comprising GLP-1 agonist and enteric coating
CN105395493B (en) * 2015-11-20 2018-02-16 南京正科医药股份有限公司 A kind of lurasidone hydrochloride tablet
US20170312226A1 (en) 2016-04-28 2017-11-02 Ascent Pharmaceuticals, Inc. Pharmaceutical dosage forms
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations
CN106822042A (en) * 2017-01-24 2017-06-13 广州帝奇医药技术有限公司 A kind of risperidone slow-release composition and preparation method thereof
CN107875122A (en) 2017-12-17 2018-04-06 佛山市弘泰药物研发有限公司 A kind of Lurasidone HCl self-micro emulsion formulation and preparation method thereof
WO2019128991A1 (en) 2017-12-26 2019-07-04 Sunshine Lake Pharma Co., Ltd. Lurasidone solid dispersion and preparation method thereof

Also Published As

Publication number Publication date
WO2020201768A1 (en) 2020-10-08

Similar Documents

Publication Publication Date Title
GB201916960D0 (en) Compositions
DK3924442T3 (en) Compositions
GB201911517D0 (en) Pharmaceutical composition
GB201807053D0 (en) Pharmaceutical composition
IL290469A (en) Oral pharmaceutical composition
GB201908396D0 (en) Compositions
ZA202006541B (en) Pharmaceutical composition comprising brexpiprazole
GB201804548D0 (en) Pharmaceutical compositions
PL3908321T3 (en) Pharmaceutical composition
GB201808571D0 (en) Pharmaceutical compositions
IL285728A (en) Pharmaceutical composition
GB201808567D0 (en) Pharmaceutical compositions
IL285389A (en) Pharmaceutical compositions comprising meloxicam
SG11202110315SA (en) Pharmaceutical composition
SG11202103374TA (en) Pharmaceutical composition
EP3914234A4 (en) Pharmaceutical compositions
IL289927A (en) New pharmaceutical formulation
PL4027974T3 (en) Pharmaceutical composition containing p-boronophenylalanine
GB201916122D0 (en) New compositions
GB201919234D0 (en) Compositions
GB201904771D0 (en) New pharmaceutical compositions
GB201904783D0 (en) New pharmaceutical compositions
GB201904785D0 (en) New pharmaceutical compositions
GB201904767D0 (en) New pharmaceutical compositions
GB201912686D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)